HIV and TB Overview: Kazakhstan

At a glance

CDC works with partners in Kazakhstan to strengthen the country's public health and clinical systems. CDC delivers quality HIV testing and treatment services and responds to emerging public health threats.

Flag of Kazakhstan

Overview

CDC partnered with the Government of Kazakhstan in 1995. Their goal was strengthening the capacity to detect, prevent, and control disease and respond to public health threats in Central Asia. In 2005, CDC began implementing activities supported through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

To help Kazakhstan achieve HIV epidemic control, CDC implements programs to identify cost-effective modes of service delivery. CDC also expands HIV prevention and treatment services for high-risk populations. CDC supports the Ministry of Health in the following areas:

  • HIV care and treatment
  • HIV prevention
  • HIV counseling and testing
  • Laboratory strengthening
  • Strategic information systems.

Download CDC Kazakhstan's Fact Sheet‎

Learn more about CDC's global HIV and TB work in Kazakhstan.

HIV and TB data

HIV/AIDS

Estimated HIV Prevalence (Ages 15-49)

Estimated AIDS Deaths (Age≥15)

Estimated Orphans Due to AIDS

Reported Number Receiving Antiretroviral Therapy (Age≥15)

Tuberculosis (TB)

Estimated TB Incidence

TB Patients with Known HIV-Status who are HIV-Positive

TB Treatment Success Rate

Key activities and accomplishments

HIV treatment centers

CDC supports five HIV treatment centers providing care and treatment services to over 5,000 people living with HIV (PLHIV). This marks an increase of 119 percent in a 5-year timespan.

Treatment initiation for PLHIV

With CDC support, timely treatment initiation for PLHIV has increased among the general and marginalized populations, such as people who inject drugs (PWID) and men who have sex with men (MSM).

Granular Site Management

CDC supported “Granular Site Management" in collaboration with ICAP and KSCDID. Its aim is to identify the existing gaps and promptly eliminate them through immediate interventions at the facility and community levels.

Improving treatment effectiveness

CDC supports interventions to improve treatment effectiveness. Specifically, continuous quality improvement of adult HIV care and treatment services and routine clinical mentoring visits to the PEPFAR sites. CDC supports nurse-led case management at the community level as well.

HIV prevention through PrEP

In 2021, CDC, in collaboration with Kazakhstan Scientific Center for Dermatology and Infectious Diseases (KSCDID), introduced pre-exposure prophylaxis (PrEP) as a method for HIV prevention among high-risk groups. Support includes technical assistance such as trainings for providers and decision-makers. As of June 30, 2023, 2,786 clients are covered with PrEP nationwide.

Nurse-led HIV treatment

CDC established a nurse-led HIV treatment and adherence program for high-risk groups, including people who inject drugs (PWID). It provides home-based follow-up for clients who are not virally suppressed. This program has led to a significant increase in viral suppression among enrollees.

Global Fund

CDC conducted a desk assessment of the HIV/AIDS laboratories in Kazakhstan in 2020. Recommendations support The Global Fund purchasing modern closed-type PCR laboratory equipment. Technical guidance was provided to The Global Fund for the lab equipment procurement.

Strengthening laboratory systems

CDC strengthened laboratory services by supporting external quality assurance assessments in all 18 HIV laboratories in the country.

Registering new treatment

CDC and KSCDID received permission from the international patent pool to purchase generic tenofovir, lamivudine, and dolutegravir (TLD), per international recommendations. With CDC’s technical support, KSCDID registered TLD treatment in Kazakhstan. The lifesaving TLD treatment will be available in Kazakhstan in 2024.

HIV case management system

KSCDID, with CDC support, developed an online electronic HIV Case Management System. It is used nationwide by all HIV/AIDS centers to have reliable, real-time data on HIV epidemics. The information is then used to make clinical and programmatic decisions.

CDC works closely with KSCDID on changing the HIV testing algorithm according to international standards.

Resources

Support for CDC's global HIV and TB efforts.‎

CDC's Division of Global HIV & TB activities are implemented as part of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); non-HIV related TB activities are supported by non-PEPFAR funding.

Our success is built on the backbone of science and strong partnerships.